NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a
rapid-acting transcription factor. It is present in almost all cell types and is one of the
primary responders to several stimuli such as stress, cytokines, radiation,
chemotherapeutic drugs, bacterial, and viral antigens. Aberrant regulation and
activation of NF-κB have been implicated in several cancers, inflammatory and
autoimmune disorders, viral infections, and erroneous immune system development.
This chapter summarizes the role of NF-κB activation specifically in hematological
malignancies and various strategies developed for its potential pharmacological
intervention to abrogate the process of carcinogenesis.
Keywords: Leukemia, Lymphoma, Myeloma, NF-κB, IKKs.
